BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34247906)

  • 21. Prognostic impact of baseline serum C-reactive protein in patients with metastatic renal cell carcinoma (RCC) treated with sunitinib.
    Beuselinck B; Vano YA; Oudard S; Wolter P; De Smet R; Depoorter L; Teghom C; Karadimou A; Zucman-Rossi J; Debruyne PR; Van Poppel H; Joniau S; Lerut E; Strijbos M; Dumez H; Paridaens R; Van Calster B; Schöffski P
    BJU Int; 2014 Jul; 114(1):81-9. PubMed ID: 24215209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic value of circulating tumour cells (CTCs) and CTC white blood cell clusters in patients with renal cell carcinoma.
    Guan Y; Xu F; Tian J; Gao K; Wan Z; Wang Y; Gao M; Wang Z; Chong T
    BMC Cancer; 2021 Jul; 21(1):826. PubMed ID: 34271857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicenter Study of Controlling Nutritional Status (CONUT) Score as a Prognostic Factor in Patients With HIV-Related Renal Cell Carcinoma.
    Xue W; Zhang Y; Wang H; Zhang Y; Hu X
    Front Immunol; 2021; 12():778746. PubMed ID: 34917092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival and impact of clinical prognostic factors in surgically treated metastatic renal cell carcinoma.
    Tosco L; Van Poppel H; Frea B; Gregoraci G; Joniau S
    Eur Urol; 2013 Apr; 63(4):646-52. PubMed ID: 23041360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative Neutrophil to Lymphocyte Ratio as a Prognostic Factor in Patients with Non-metastatic Renal Cell Carcinoma.
    Wen RM; Zhang YJ; Ma S; Xu YL; Chen YS; Li HL; Bai J; Zheng JN
    Asian Pac J Cancer Prev; 2015; 16(9):3703-8. PubMed ID: 25987025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of hematologic parameters in patients with metastatic renal cell carcinoma using tyrosine kinase inhibitors.
    Gunduz S; Mutlu H; Uysal M; Coskun HS; Bozcuk H
    Asian Pac J Cancer Prev; 2014; 15(8):3801-4. PubMed ID: 24870797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High YKL-40 is associated with poor survival in patients with renal cell carcinoma: a novel independent prognostic marker.
    Väänänen T; Kallio J; Vuolteenaho K; Ojala A; Luukkaala T; Hämäläinen M; Tammela T; Kellokumpu-Lehtinen PL; Moilanen E
    Scand J Urol; 2017 Oct; 51(5):367-372. PubMed ID: 28644702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of preoperative neutrophil-to-lymphocyte ratio in papillary renal cell carcinoma patients after receiving curative surgery based on a retrospective cohort.
    Zhang Z; Yu Y; Zheng J; Zhang M; Niu H
    BMC Urol; 2021 Mar; 21(1):43. PubMed ID: 33752642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender differences in clinicopathological features and survival in surgically treated patients with renal cell carcinoma: an analysis of the multicenter CORONA database.
    May M; Aziz A; Zigeuner R; Chromecki T; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Tubaro A; Coman I; Truss M; Dalpiaz O; Hoschke B; Gilfrich C; Feciche B; Stoltze A; Fenske F; Fritsche HM; Figenshau RS; Madison K; Sánchez-Chapado M; Martin Mdel C; Salzano L; Lotrecchiano G; Joniau S; Waidelich R; Stief C; Brookman-May S;
    World J Urol; 2013 Oct; 31(5):1073-80. PubMed ID: 23568445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic implications of sarcomatoid and rhabdoid differentiation in patients with grade 4 renal cell carcinoma.
    Kara O; Maurice MJ; Zargar H; Malkoc E; Akca O; Andrade HS; Ramirez D; Caputo PA; Nelson RJ; Rini B; Kaouk JH
    Int Urol Nephrol; 2016 Aug; 48(8):1253-1260. PubMed ID: 27215555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effect of Preoperative Apolipoprotein A-I on the Prognosis of Surgical Renal Cell Carcinoma: A Retrospective Large Sample Study.
    Guo S; He X; Chen Q; Yang G; Yao K; Dong P; Ye Y; Chen D; Zhang Z; Qin Z; Liu Z; Li Z; Xue Y; Zhang M; Liu R; Zhou F; Han H
    Medicine (Baltimore); 2016 Mar; 95(12):e3147. PubMed ID: 27015197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. De Ritis ratio (aspartate transaminase/alanine transaminase ratio) as a significant prognostic factor after surgical treatment in patients with clear-cell localized renal cell carcinoma: a propensity score-matched study.
    Lee H; Lee SE; Byun SS; Kim HH; Kwak C; Hong SK
    BJU Int; 2017 Feb; 119(2):261-267. PubMed ID: 27226065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
    Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
    BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative Neutrophil-lymphocyte Ratio as a Predictor of Overall Survival in Patients with Localized Renal Cell Carcinoma.
    Widz D; Mitura P; Buraczynski P; Plaza P; Bar M; Cabanek M; Nowak G; Ostrowska A; Bar K
    Urol J; 2020 Jan; 17(1):30-35. PubMed ID: 31087321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of extent of venous tumor thrombus in patients with non-metastatic renal cell carcinoma: Results from a Canadian multi-institutional collaborative.
    Shiff B; Breau RH; Mallick R; Pouliot F; So A; Tanguay S; Kapoor A; Lattouf JB; Lavallée L; Fairey A; Finelli A; Bhindi B; Kawakami J; Rendon R; Bansal RK
    Urol Oncol; 2021 Dec; 39(12):836.e19-836.e27. PubMed ID: 34556430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinoma.
    Hutterer GC; Stoeckigt C; Stojakovic T; Jesche J; Eberhard K; Pummer K; Zigeuner R; Pichler M
    Urol Oncol; 2014 Oct; 32(7):1041-8. PubMed ID: 25027686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of modified Glasgow Prognostic Score in patients with non-metastatic clear cell renal cell carcinoma.
    Cho DS; Kim SI; Choo SH; Jang SH; Ahn HS; Kim SJ
    Scand J Urol; 2016 Jun; 50(3):186-91. PubMed ID: 26878156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of hemoglobin-to-red cell distribution width ratio in patients with metastatic renal cancer.
    Yılmaz H; Yılmaz A; Demirağ G
    Future Oncol; 2021 Oct; 17(29):3853-3864. PubMed ID: 34382414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal cell carcinoma in young patients is associated with poorer prognosis.
    Lee LS; Yuen JS; Sim HG
    Ann Acad Med Singap; 2011 Sep; 40(9):401-6. PubMed ID: 22065033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The natural history of renal cell carcinoma with isolated lymph node metastases following surgical resection from 2006 to 2013.
    Golijanin B; Pereira J; Mueller-Leonhard C; Golijanin D; Amin A; Mega A; Boorjian SA; Thompson RH; Leibovich BC; Gershman B
    Urol Oncol; 2019 Dec; 37(12):932-940. PubMed ID: 31570248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.